Yazan Migdady, MD, MSc

Financial relationships

  • Attribution:
    Self
    Nature of financial relationship:
    Other
    Ineligible company:
    Servier Pharmaceuticals LLC
    Topic:
    AML advisory boards
    Date added:
    10/15/2024
    Date updated:
    10/15/2024
    Relationship end date:
    09/18/2024
  • Attribution:
    Self
    Nature of financial relationship:
    Other
    Ineligible company:
    Medexus pharmaceuticals
    Topic:
    Treosulfan advisory boards
    Date added:
    10/15/2024
    Date updated:
    10/15/2024
    Relationship end date:
    09/19/2024
  • Attribution:
    Self
    Nature of financial relationship:
    Other
    Ineligible company:
    Rigel Pharmaceuticals
    Topic:
    AML advisory boards
    Date added:
    10/15/2024
    Date updated:
    10/15/2024
    Relationship end date:
    09/22/2024
Return to 14th Annual Updates in the Treatment and Management of Hematologic Malignancies Highlights from San Diego